Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 6, 2008, Pages 1711-1717

  Badve, Sunil V ^a,b   Zimmerman, Deborah L ^a,b   Knoll, Greg A ^a,b   Burns, Kevin D ^a,b   McCormick, Brendan B ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PHOSPHATE; UREA;

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERPHOSPHATEMIA; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; RETROSPECTIVE STUDY; TIME;

ADULT; AGED; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PHOSPHATES; RETROSPECTIVE STUDIES; TIME FACTORS; UREA;

EID: 58149327151     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00190108     Document Type: Article

References (21)

1. Ansell D: Serum phosphate and outcomes in PD patients. Nephrol Dial Transplant 22: 667-668, 2007
2. Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT: Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 21: 2513-2520, 2006
3. Rufino M, de Bonis E, Martin M, Rebollo S, Martin B, Miguel R, Cobo M, Hernandez D, Torres A, Lorenzo V: Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant 13: 65-67, 1998
4. 3): An efficient and safe phosphate binder in haemodialysis patients? A 3-year study. Nephrol Dial Transplant 8: 530-534, 1993
5. Curtin RB, Svarstad BL, Keller TH: Hemodialysis patients' noncompliance with oral medications. ANNA J 26: 307-316, 1999
6. Wang AY, Woo J, Sea MM, Law MC, Lui SF, Li PK: Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: What are the implications? Am J Kidney Dis 43: 712-720, 2004
7. Zehnder C, Gutzwiller JP, Renggli K: Hemodiafiltration-a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 52: 152-159, 1999
8. Nolph KD, Twardowski ZJ, Popovich RP, Rubin J: Equilibration of peritoneal dialysis solutions during long-dwell exchanges. J Lab Clin Med 93: 246-256, 1979
9. Sedlacek M, Dimaano F, Uribarri J: Relationship between phosphorus and creatinine clearance in peritoneal dialysis: Clinical implications. Am J Kidney Dis 36: 1020-1024, 2000
10. Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y: Superior dialytic clearance of [beta]2-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis. Kidney Int 70: 794-799, 2006
11. Gallar P, Ortega O, Gutierrez M, Munoz M, Hilara L, Oliet A, Rodriguez I, Gimenez E, Vigil A: Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options. [Spanish]. Nefrologia 20: 355-361, 2000
12. Twardowski Z, Nolph KO, Khanna R, Prowant BF, Ryan LP, Moore HL, Neilsen MP: Peritoneal equilibration test. Perit Dial Int 7: 138-148, 1987
13. Twardowski ZJ, Nolph KD, Khanna R, Gluck Z, Prowant BF, Ryan LP: Daily clearances with continuous ambulatory peritoneal dialysis and nightly peritoneal dialysis. ASAIO Trans 32: 575-580, 1986
14. Venkataraman V, Nolph KD: Utilisation of PD modalities: Evolution. Semin Dial 15: 380-384, 2002
15. Mujais S, Story K: Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts. Kidney Int 70: S21-S26, 2006
16. Wilson J, Nissenson AR: Determinants in APD selection. Semin Dial 15: 388-392, 2002
17. Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, Blake PG, ISPD Adequacy of Peritoneal Dialysis Working Group: Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int 26: 520-522, 2006
18. National Kidney Foundation. Clinical practice recommendations for peritoneal dialysis adequacy. Am J Kidney Dis 48: S130-S158, 2006
19. Kim DJ, Do JH, Huh W, Kim YG, Oh HY: Dissociation between clearances of small and middle molecules in incremental peritoneal dialysis. Perit Dial Int 21: 462-466, 2001
20. Juergensen P, Eras J, McClure B, Kliger AS, Finkelstein FO: The impact of various cycling regimens on phosphorus removal in chronic peritoneal dialysis patients. Int J Artif Organs 28: 1219-1223, 2005
21. Juergensen PH, Murphy AL, Kliger AS, Finkelstein FO: Increasing the dialysis volume and frequency in a fixed period of time in CPD patients: The effect on Kpt/V and creatinine clearance. Perit Dial Int 22: 693-697, 2002